VCEL Q3 2022 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena

VCELVericel Corporation

$2B

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$39M+11.7% YoY

Gross Profit

$25M65.5% margin

Operating Income

-$7M-17.6% margin

Net Income

-$7M-17.1% margin

EPS (Diluted)

$-0.14

QoQ Revenue Growth

+4.1%

Cash Flow

Operating Cash Flow

$4M

Free Cash Flow

$3M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$248M

Total Liabilities

$70M

Stockholders' Equity

$178M

Cash & Equivalents

$65M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$39M	$35M	+11.7%
Gross Profit	$25M	$22M	+14.2%
Operating Income	-$7M	-$5M	-36.8%
Net Income	-$7M	-$5M	-33.4%

Revenue Segments

MACI Implants And Kits Member

$31M100%